Cannabis Bioscience International Holdings, Inc.
CBIH
$0.0008
$0.000114.29%
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -58.52% | 135.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -58.52% | 135.70% | |||
| Cost of Revenue | -7.14% | -15.15% | |||
| Gross Profit | -61.06% | 158.33% | |||
| SG&A Expenses | -52.97% | 180.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -51.57% | 162.09% | |||
| Operating Income | 38.93% | -229.73% | |||
| Income Before Tax | -4.19% | 43.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.19% | 43.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.19% | 43.86% | |||
| EBIT | 38.93% | -229.73% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.37% | 1.37% | |||
| Average Diluted Shares Outstanding | 0.37% | 1.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
